


Healthcare News Roundup: Neuro
HSMN NewsFeed - 27 Mar 2009
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
HSMN NewsFeed - 25 Mar 2009
Spinal Elements, Inc. and Paradigm BioDevices, Inc. Form Strategic Alliance
Spinal Elements, Inc. and Paradigm BioDevices, Inc. Form Strategic Alliance
HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
HSMN NewsFeed - 18 Mar 2009
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
HSMN NewsFeed - 3 Mar 2009
Integra LifeSciences Names Christopher Thatcher President of Integra NeuroSciences
Integra LifeSciences Names Christopher Thatcher President of Integra NeuroSciences
HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
HSMN NewsFeed - 11 Feb 2009
UT Southwestern Performs First Local Implant in Deep Brain Stimulation Study for Depression
UT Southwestern Performs First Local Implant in Deep Brain Stimulation Study for Depression
HSMN NewsFeed - 10 Feb 2009
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
HSMN NewsFeed - 4 Feb 2009
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
HSMN NewsFeed - 3 Feb 2009
Globus Medical's SIGNATURE(TM) Spacer Designed for MILDER(TM) TLIF Procedures
Globus Medical's SIGNATURE(TM) Spacer Designed for MILDER(TM) TLIF Procedures
